|
AVTR
|
Avantor, Inc.
|
0.23%
|
US
|
NYSE
|
|
TECH
|
Techne Corporation
|
0.22%
|
US
|
NASDAQ
|
|
UTHR
|
United Therapeutics Corporation
|
0.21%
|
US
|
NASDAQ
|
|
TFX
|
Teleflex Incorporated
|
0.21%
|
US
|
NYSE
|
|
NBIX
|
Neurocrine Biosciences, Inc.
|
0.20%
|
US
|
NASDAQ
|
|
HSIC
|
Henry Schein, Inc.
|
0.19%
|
US
|
NASDAQ
|
|
CRL
|
Charles River Laboratories International, Inc.
|
0.19%
|
US
|
NYSE
|
|
NVCR
|
NovoCure Limited
|
0.18%
|
US
|
NASDAQ
|
|
JAZZ
|
Jazz Pharmaceuticals plc
|
0.17%
|
US
|
NASDAQ
|
|
UHS
|
Universal Health Services, Inc.
|
0.17%
|
US
|
NYSE
|
|
SRPT
|
Sarepta Therapeutics, Inc.
|
0.16%
|
US
|
NASDAQ
|
|
BIO
|
Bio-Rad Laboratories, Inc.
|
0.16%
|
US
|
NYSE
|
|
RGEN
|
Repligen Corporation
|
0.14%
|
US
|
NASDAQ
|
|
EXAS
|
Exact Sciences Corporation
|
0.14%
|
US
|
NASDAQ
|
|
CTLT
|
Catalent, Inc.
|
0.14%
|
US
|
NYSE
|
|
PEN
|
Penumbra, Inc.
|
0.14%
|
US
|
NYSE
|
|
SWAV
|
ShockWave Medical, Inc.
|
0.13%
|
US
|
NASDAQ
|
|
MASI
|
Masimo Corporation
|
0.13%
|
US
|
NASDAQ
|
|
HALO
|
Halozyme Therapeutics, Inc.
|
0.13%
|
US
|
NASDAQ
|
|
ACHC
|
Acadia Healthcare Company, Inc.
|
0.13%
|
US
|
NASDAQ
|